The US Bankruptcy Court approved conditionally the second revised disclosure statement and plan of Timber Pharmaceuticals, Inc. on March 20, 2024. The debtor had filed its second revised disclosure statement in the Court on March 20, 2024. March 19, 2024 has been fixed as voting record date.

The deadline to vote on the plan is April 22, 2024 and the plan objection deadline is April 19, 2024. The confirmation hearing for the plan has been scheduled for May 2, 2024.